Status:
UNKNOWN
Dexamethasone-bupivacaine Versus Bupivacaine for Tonsillectomy Pain.
Lead Sponsor:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Tonsillectomy
Eligibility:
All Genders
2-12 years
Phase:
PHASE4
Brief Summary
Investigators compared in this study peritonsillar infiltration of bupivacaine %0.5 (n=40 participants) versus bupivacaine % 0.5 and dexamethasone (number 40participants ) before surgery for reduce po...
Detailed Description
Bupivacaine hydrochloride amid structure,long acting local anesthetic. Dexamethasone has strong anti-inflammatory drug reduce postoperative pain and nause and vomiting.Preoperative iv dexamethasone is...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Tonsillectomy surgery for recurrent tonsillitis Sleep disorder breathing
- ExclusionCriteria:
- Patients with active upper respiratory tract infection Patients with significant cognitive impairment Bupivacaine hypersensitivity Dexamethasone hypersensitivity Taking chronic systemic steroids
Exclusion
Key Trial Info
Start Date :
December 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 15 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03443778
Start Date
December 15 2017
End Date
April 15 2018
Last Update
February 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leyla Kilinc
Istanbul, Sisli, Turkey (Türkiye), 34360